InfuSystem Holdings, Inc. vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 6 of 9 compared factors.
Size & Scale
| INFU | RMD | |
|---|---|---|
| Market Cap | $252.95 million | $32.02 billion |
| Revenue (TTM) | $143.34 million | $5.65 billion |
| Net Income (TTM) | $8.54 million | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| INFU | RMD | |
|---|---|---|
| P/E Ratio | 31.75 | 21.31 |
| Price / Book | 4.28 | 4.86 |
| Price / Sales | 1.76 | 5.66 |
INFU leads on 2 of 3 valuation factors.
Profitability
| INFU | RMD | |
|---|---|---|
| Net Margin | 5.96% | 26.94% |
| Return on Equity | 14.44% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| INFU | RMD | |
|---|---|---|
| Dividend Yield | — | 1.19% |
| Payout Ratio | — | 25.31 |
INFU and RMD split the dividend factors evenly.
Risk & Sentiment
| INFU | RMD | |
|---|---|---|
| Short Interest | 0.02% | 4.04% |
INFU leads on 1 of 1 risk & sentiment factors.
Dig deeper: INFU overview, INFU financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.